17 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
the investigational drug receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy. The posting
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
the investigational drug receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy. The posting
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
the investigational drug receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy. The posting of the expanded
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
study, or as applicable, 15 days after the investigational drug receives designation as a breakthrough therapy, fast track product, or regenerative
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:28pm
, or as applicable, 15 days after the investigational drug receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced
DRS/A
3pqss4ogi
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next